BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 24616394)

  • 21. Translational genomics is not a spectator sport: a call to action.
    Boerwinkle E
    Genet Epidemiol; 2012 Feb; 36(2):85-7. PubMed ID: 22851471
    [No Abstract]   [Full Text] [Related]  

  • 22. Strategies for personalized medicine-based research and implementation in the clinical workflow.
    Lieb W; Völzke H; Pulley JM; Roden DM; Kroemer HK
    Clin Pharmacol Ther; 2012 Oct; 92(4):443-5. PubMed ID: 22910438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asymmetry in scientific method and limits to cross-disciplinary dialogue: toward a shared language and science policy in pharmacogenomics and human disease genetics.
    Ozdemir V; Williams-Jones B; Graham JE; Preskorn SH; Gripeos D; Glatt SJ; Friis RH; Reist C; Szabo S; Lohr JB; Someya T
    J Investig Med; 2007 Apr; 55(3):130-41. PubMed ID: 17481382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical genomics: Gather and use genetic data in health care.
    Ginsburg G
    Nature; 2014 Apr; 508(7497):451-3. PubMed ID: 24765668
    [No Abstract]   [Full Text] [Related]  

  • 25. Francis Collins interview. Departing U.S. genome institute director takes stock of personalized medicine. Interview by Jocelyn Kaiser.
    Collins F
    Science; 2008 Jun; 320(5881):1272. PubMed ID: 18535215
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetics and primary care: where are we headed?
    Rahimzadeh V; Bartlett G
    J Transl Med; 2014 Aug; 12():238. PubMed ID: 25164605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic medicine frontier in human solid tumors: prospects and challenges.
    Dienstmann R; Rodon J; Barretina J; Tabernero J
    J Clin Oncol; 2013 May; 31(15):1874-84. PubMed ID: 23589551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From microarrays to genome duplications.
    Roth C; Hughes T
    Genome Biol; 2003; 4(8):332. PubMed ID: 12914655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The SickKids Genome Clinic: developing and evaluating a pediatric model for individualized genomic medicine.
    Bowdin SC; Hayeems RZ; Monfared N; Cohn RD; Meyn MS
    Clin Genet; 2016 Jan; 89(1):10-9. PubMed ID: 25813238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Institutional profile: translational pharmacogenomics at the Icahn School of Medicine at Mount Sinai.
    Scott SA; Owusu Obeng A; Botton MR; Yang Y; Scott ER; Ellis SB; Wallsten R; Kaszemacher T; Zhou X; Chen R; Nicoletti P; Naik H; Kenny EE; Vega A; Waite E; Diaz GA; Dudley J; Halperin JL; Edelmann L; Kasarskis A; Hulot JS; Peter I; Bottinger EP; Hirschhorn K; Sklar P; Cho JH; Desnick RJ; Schadt EE
    Pharmacogenomics; 2017 Oct; 18(15):1381-1386. PubMed ID: 28982267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integration of genomics into medical practice.
    Korf BR
    Discov Med; 2013 Nov; 16(89):241-8. PubMed ID: 24229741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A critique of race-based and genomic medicine.
    Meier RJ
    Coll Antropol; 2012 Mar; 36(1):5-10. PubMed ID: 22816192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The increasing role of genetics and genomics in women's health.
    Klein EL
    Nurs Womens Health; 2014; 18(2):149-53. PubMed ID: 24750654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenomics and individualized medicine: translating science into practice.
    Crews KR; Hicks JK; Pui CH; Relling MV; Evans WE
    Clin Pharmacol Ther; 2012 Oct; 92(4):467-75. PubMed ID: 22948889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group.
    Teutsch SM; Bradley LA; Palomaki GE; Haddow JE; Piper M; Calonge N; Dotson WD; Douglas MP; Berg AO;
    Genet Med; 2009 Jan; 11(1):3-14. PubMed ID: 18813139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prospects of medicinal use of achievements in genomics: the beginning of era of complete genome medical genetics].
    Sverdlov ED
    Patol Fiziol Eksp Ter; 2001; (1):3-22. PubMed ID: 11247299
    [No Abstract]   [Full Text] [Related]  

  • 37. The promise of whole-exome sequencing in medical genetics.
    Rabbani B; Tekin M; Mahdieh N
    J Hum Genet; 2014 Jan; 59(1):5-15. PubMed ID: 24196381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Triple negative breast cancer": Translational research and the (re)assembling of diseases in post-genomic medicine.
    Keating P; Cambrosio A; Nelson NC
    Stud Hist Philos Biol Biomed Sci; 2016 Oct; 59():20-34. PubMed ID: 27235853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Institutional profile: The Carney Centre for Pharmacogenomics: a New Zealand focus for personalized medicine research.
    Kennedy MA; Joyce PR; Begg EJ
    Pharmacogenomics; 2012 Jun; 13(8):865-8. PubMed ID: 22676191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetics and genomics: the scientific drivers of personalized medicine.
    Kurnat-Thoma EL
    Annu Rev Nurs Res; 2011; 29():27-54. PubMed ID: 22891497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.